Lecithin-Emulsified Cannabis Compositions for Bioavailability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical treatments for pain, nausea, vomiting, and anorexia in conditions like AIDS and chemotherapy-induced side effects are limited in efficacy and convenience, particularly in terms of natural origin cannabinoids' delivery and dosing.
Innovation Solution
Compositions comprising hemp seed powder, soy lecithin, and cannabis, optionally with excipients, are developed for improved dispersion and delivery of cannabinoids, providing a consistent texture and enhanced bioavailability, and are formulated into kits for sequential dosing with instructions for use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If synthetic cannabinoids like dronabinol are used, then therapeutic efficacy is improved, but natural origin and safety profile deteriorate
Solution Approach 1:
The patent uses lecithin as an intermediary substance to deliver natural cannabinoids to the bloodstream. The lecithin emulsion acts as a mediator that enhances the bioavailability of natural cannabinoids extracted from cannabis plants, allowing them to effectively cross the intestinal mucosa without requiring synthetic modification of the cannabinoids themselves.
Solution Approach 2:
The patent changes the physical state and delivery parameters of natural cannabinoids by converting them into a lecithin emulsion form. This parameter change enhances their solubility and bioavailability, allowing natural cannabinoids to achieve therapeutic efficacy comparable to synthetic versions while maintaining their natural safety profile.
2Object-generated harmful factors
If natural cannabinoids are used, then safety profile is improved, but bioavailability and therapeutic efficacy deteriorate
Solution Approach 1:
Lecithin serves as a natural intermediary that facilitates the absorption of cannabinoids. The phospholipid structure of lecithin creates an emulsion that mimics cellular membrane structures, enabling natural cannabinoids to more effectively penetrate the intestinal mucosa and enter the bloodstream while maintaining their natural chemical structure and safety profile.
Solution Approach 2:
The patent creates a composite delivery system combining natural cannabinoids with lecithin emulsion. This composite material leverages the natural safety of cannabinoids while the lecithin component provides enhanced bioavailability through its emulsifying properties, achieving both safety and therapeutic efficacy.
3Reliability
If powdered hemp seed and lecithin are added to compositions, then dispersion and bioavailability are improved, but manufacturing complexity increases
Solution Approach 1:
The patent combines multiple functional components into a single integrated composition: powdered hemp seed provides dispersion and additional beneficial nutrients, lecithin provides emulsification and enhanced bioavailability, and cannabis provides the active cannabinoids. This merging of functions into one composition simplifies the manufacturing process compared to producing separate formulations for each function.
Solution Approach 2:
The lecithin component serves multiple functions simultaneously: it acts as an emulsifier to disperse cannabinoids, enhances bioavailability by facilitating mucosal crossing, and provides a stable delivery vehicle. The powdered hemp seed also serves multiple roles including dispersion medium, source of additional nutrients, and texture modifier. This multi-functionality reduces the need for additional manufacturing steps.
4Ease of operation
If sequential dosing kits are implemented, then patient convenience is improved, but device complexity increases
Solution Approach 1:
The patent divides the total treatment dosage into multiple sequential units packaged in a kit. Each unit contains a specific dose of the lecithin-emulsified cannabinoid composition, allowing patients to administer treatment in controlled increments. This segmentation provides convenience through controlled dosing while the kit structure organizes the complexity externally rather than requiring complex internal mechanisms.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compositions effectively treat pain, nausea, vomiting, and anorexia by providing a consistent and bioavailable form of cannabinoids, enhancing therapeutic efficacy and patient convenience through controlled dosing and administration.
Implementation Method 1
compositions comprising powdered hemp seed, an emulsifier/dispersant such as lecithin (particularly soy lecithin), cannabis
Implementation Method 2
an emulsifier/dispersant such as lecithin
Data Source
AI summary
Disclosed here are compositions comprising powdered hemp seed, an emulsifier/dispersant such as lecithin (particularly soya lecithin), cannabis, and optionally other additives and excipients. Also described are methods of making the compositions. The compositions may be used, for instance, in the treatment of pain and for their anti-emetic (anti-nausea and anti-vomiting) properties, as well as for the treatment of anorexia and appetite enhancement. Kits containing the compositions, arranged for proper sequential dosing, and optionally including instructions for use are also disclosed.